Search research articles
Contact Us
Filters
Showing results (1-10 of 240) with videos related to
Page
of 24
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 29, 2025
Cardiovascular disease and cardiovascular pharmacotherapy: the challenges and the research continue
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 8, 2016
Cardiovascular pharmacotherapy-2015 was a good year
Basil S Lewis
European Heart Journal
|
July 28, 2016
CardioPulse: Coronary artery disease from prevention to intervention
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 9, 2021
Atrial fibrillation and stroke prevention
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 30, 2023
First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 6, 2023
Factor XIa inhibitors: collecting the clinical evidence
Basil S Lewis, Koji Hasegawa
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Basil S Lewis, Stefan Agewall
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 28, 2022
Are SGLT2 inhibitors effective against 'all' heart failure with preserved ejection fraction?
Koji Hasegawa, Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 28, 2018
Peripheral arterial disease and limb salvage: a new arena for the cardiologist
Basil S Lewis, Dan Atar
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
May 4, 2004
Acquired partially flail leaflet causing severe mitral regurgitation in a congenital double-orifice mitral valve
Avinoam Shiran, Basil S Lewis
Page
of 24
Search research articles
Search
Showing results (1-10 of 240) with videos related to
Sort By:
Page
of 24
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 29, 2025
Cardiovascular disease and cardiovascular pharmacotherapy: the challenges and the research continue
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 8, 2016
Cardiovascular pharmacotherapy-2015 was a good year
Basil S Lewis
European Heart Journal
|
July 28, 2016
CardioPulse: Coronary artery disease from prevention to intervention
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 9, 2021
Atrial fibrillation and stroke prevention
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 30, 2023
First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA
Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
November 6, 2023
Factor XIa inhibitors: collecting the clinical evidence
Basil S Lewis, Koji Hasegawa
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Basil S Lewis, Stefan Agewall
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 28, 2022
Are SGLT2 inhibitors effective against 'all' heart failure with preserved ejection fraction?
Koji Hasegawa, Basil S Lewis
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 28, 2018
Peripheral arterial disease and limb salvage: a new arena for the cardiologist
Basil S Lewis, Dan Atar
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
May 4, 2004
Acquired partially flail leaflet causing severe mitral regurgitation in a congenital double-orifice mitral valve
Avinoam Shiran, Basil S Lewis
Page
of 24